Your account is not claimed yet. You can sign up with ORCID to claim your account.

Francesc Vidal

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Venues

Clinical and translational medicine

Expert opinion on pharmacotherapy

Clinical science (London, England : 1979)

Universitat Rovira i Virgili

Universitat de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat Rovira i Virgili

Spain

Professor :: Medicine and Surgery

Education History

Universitat de Barcelona

Spain

PHD

Publications

Jenifer Masip, Carmen Gasca-Capote, María Reyes Jimenez-Leon, Joaquim Peraire, Alberto Perez-Gomez, Verónica Alba, Ana-Irene Malo, Lorna Leal, Carmen Rodríguez Martín, Norma Rallón, Consuelo Viladés, Montserrat Olona, Francesc Vidal, Ezequiel Ruiz-Mateos, Anna Rull, null null
Differential miRNA plasma profiles associated with the spontaneous loss of HIV-1 control: miR-199a-3p and its potential role as a biomarker for quick screening of elite controllers. Clinical and translational medicine 11 (7) (2022)
Laia Reverté, Elena Yeregui, Montserrat Olona, Alicia Gutiérrez-Valencia, Maria José Buzón, Anna Martí, Frederic Gómez-Bertomeu, Teresa Auguet, Luis F López-Cortés, Joaquin Burgos, Clara Benavent-Bofill, Carme Boqué, Graciano García-Pardo, Ezequiel Ruiz-Mateos, Maria Teresa Mestre, Francesc Vidal, Consuelo Viladés, Joaquim Peraire, Anna Rull, null null
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes. Clinical and translational medicine 12 (1) (2022)
Noemí Corbacho, Isabel Mur, Maria Ema Molas, Francesc Vidal, Pere Domingo
The pharmacological management of cardiovascular disease in people living with HIV (PLWH). Expert opinion on pharmacotherapy 22 (6) (2021)
María Del Mar Gutierrez, Isabel Mur, María Gracia Mateo, Francesc Vidal, Pere Domingo
Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH). Expert opinion on pharmacotherapy 22 (9) (2021)
Isaac Rosado-Sánchez, Esther Rodríguez-Gallego, Joaquim Peraire, Consuelo Viladés, Pol Herrero, Fran Fanjul, Félix Gutiérrez, Enrique Bernal, Ricardo Pelazas, Manuel Leal, Sergi Veloso, Miguel López-Dupla, Julià Blanco, Francesc Vidal, Yolanda María Pacheco, Anna Rull
Glutaminolysis and lipoproteins are key factors in late immune recovery in successfully treated HIV-infected patients. Clinical science (London, England : 1979) 133 (8) (2019)

Francesc Vidal.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Francesc Vidal